Currently out of the existing stock ratings of Yaoxian Chew, 5 are a HOLD (83.33%), 1 are a BUY (16.67%).

Yaoxian Chew

Work Performance Price Targets & Ratings Chart

Analyst Yaoxian Chew, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 100% that have a potential upside of 19.25% achieved within 276 days.

Yaoxian Chew’s has documented 28 price targets and ratings displayed on 3 stocks. The coverage is on the Technology sector.

Most recent stock forecast was given on INTU, Intuit at 25-May-2022.

Wall Street Analyst Yaoxian Chew

Analyst best performing recommendations are on MDLA (MEDALLIA).
The best stock recommendation documented was for CDAY (CERIDIAN HCM) at 2/10/2021. The price target of $95 was fulfilled within 1 day with a profit of $3.99 (4.38%) receiving and performance score of 43.84.

Average potential price target upside

CDAY Ceridian HCM MDLA Medallia INTU Intuit

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 10-Feb-2023

$86

$16.48 (23.71%)

$86

1 years 11 months 18 days ago
(19-Jan-2024)

1/3 (33.33%)

$19.74 (29.79%)

22

Buy

Since 03-Jan-2019

$82

$12.48 (17.95%)

$82

2 years 1 months 1 days ago
(05-Dec-2023)

7/10 (70%)

$14.8 (22.02%)

101

Buy

Since 23-Mar-2022

$87

$17.48 (25.14%)

$87

2 years 1 months 30 days ago
(07-Nov-2023)

1/6 (16.67%)

$20.95 (31.72%)

181

Hold

Since 03-Nov-2022

$62

$-7.52 (-10.82%)

$65

2 years 2 months 4 days ago
(02-Nov-2023)

5/6 (83.33%)

$-5.08 (-7.57%)

189

Hold

Since 21-May-2020

$73

$3.48 (5.01%)

$73

2 years 2 months 25 days ago
(12-Oct-2023)

9/14 (64.29%)

$-0.04 (-0.05%)

50

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Yaoxian Chew?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?